Impact of genetic changes in the Enterovirus 71 genome on virulence
Enterovirus 71 (EV-A71) is one of the main etiological agents of hand, foot and mouth disease (HFMD). EV-A71 mainly infects infants and young children below six years of age. Clinical manifestations of HFMD include fever, rashes with the presence of vesicles on the hand, feet and mouth. However, the...
| Main Authors: | Poh, Chit Laa *, Mandary, M. B., Ong, Seng Kai * |
|---|---|
| Format: | Book Section |
| Language: | English |
| Published: |
CRC Press
2019
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/1191/ http://eprints.sunway.edu.my/1191/1/Virus_Chapter_Poh%20Chit%20Laa.docx |
Similar Items
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)
by: Lalani, S.*, et al.
Published: (2021)
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)
by: Masomian, Malihe *, et al.
Published: (2021)
T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
Characterization of plaque variants and the involvement of Quasi-Species in a population of EV-A71
by: Mandary, M. B. *, et al.
Published: (2020)
by: Mandary, M. B. *, et al.
Published: (2020)
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)
by: Roberts, Ryan, et al.
Published: (2019)
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
Pluripotent human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
by: Yap, May Shin *, et al.
Published: (2016)
by: Yap, May Shin *, et al.
Published: (2016)
The conserved molecular determinants of virulence in
dengue virus
by: Zuleeza A,, et al.
Published: (2019)
by: Zuleeza A,, et al.
Published: (2019)
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)
by: Lim, Hui Xuan *, et al.
Published: (2019)
High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)
by: Tan, Cheng Siang, et al.
Published: (2007)
Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice
by: Lalani, Salima, et al.
Published: (2021)
by: Lalani, Salima, et al.
Published: (2021)
Recent advances in delivery of veterinary DNA vaccines against avian pathogens
by: Jazayeri, S. D. *, et al.
Published: (2019)
by: Jazayeri, S. D. *, et al.
Published: (2019)
Development of universal influenza vaccines targeting conserved viral proteins
by: Jazayeri, S. D. *, et al.
Published: (2019)
by: Jazayeri, S. D. *, et al.
Published: (2019)
Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
Structural vaccinology for viral vaccine design
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)
by: Chew, Miaw Fang *, et al.
Published: (2017)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)
by: Tan, Le Van, et al.
Published: (2015)
Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)
by: Anasir, M. I. *, et al.
Published: (2020)
Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine
by: Lim, Hui Xuan *, et al.
Published: (2021)
by: Lim, Hui Xuan *, et al.
Published: (2021)
Understanding the differentiation, expansion, recruitment and suppressive activities of myeloid-derived suppressor cells in cancers
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles
by: Chan, Yanqi, et al.
Published: (2020)
by: Chan, Yanqi, et al.
Published: (2020)
Development of next generation Streptococcus pneumoniae vaccines conferring broad protection
by: Masomian, Malihe *, et al.
Published: (2020)
by: Masomian, Malihe *, et al.
Published: (2020)
Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)
by: Ooi, Mong How, et al.
Published: (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)
by: Solomon, Tom, et al.
Published: (2010)
Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)
by: Wong, Rui Rui, et al.
Published: (2020)
Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases
by: Jazayeri, S. D. *, et al.
Published: (2021)
by: Jazayeri, S. D. *, et al.
Published: (2021)
RSAD2 and AIM2 modulateCV-A16 and EV-A71 replication in neuronal cells in different ways that may be associated with their 5′ non-translated regions
by: David, Perera
Published: (2017)
by: David, Perera
Published: (2017)
Novel Multiplex Oligonucleotide-Conjugated Bead Suspension Array for Rapid Identification of Enterovirus 71 Subgenogroups
by: Wu, Y., et al.
Published: (2011)
by: Wu, Y., et al.
Published: (2011)
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
Near-complete genome sequences of Nine SARS-CoV-2 strains harboring the D614G mutation in Malaysia
by: Ummu Afeera, Zainulabid, et al.
Published: (2021)
by: Ummu Afeera, Zainulabid, et al.
Published: (2021)
Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease
by: Ong, Kien Chai, et al.
Published: (2010)
by: Ong, Kien Chai, et al.
Published: (2010)
Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
Sequence and genome analysis of hepatitis C virus
by: Hamzah, Hairul Aini
Published: (2017)
by: Hamzah, Hairul Aini
Published: (2017)
Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA
by: Wong, K.T., et al.
Published: (2012)
by: Wong, K.T., et al.
Published: (2012)
Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16.
by: Thao, Nguyen Thi Thanh, et al.
Published: (2010)
by: Thao, Nguyen Thi Thanh, et al.
Published: (2010)
Similar Items
-
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017) -
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020) -
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015) -
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021) -
Molecular docking of SP40 peptide towards cellular
receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)